Exposure to mass media health information, skin cancer beliefs, and sun protection behaviors in a United States probability sample - 07/08/11
, Elliot J. Coups, PhD b, Jennifer Ford, PhD a, Marco DiBonaventura, PhD c
Reprint requests: Jennifer Hay, PhD, Memorial Sloan-Kettering Cancer Center, Department of Psychiatry and Behavioral Sciences, 641 Lexington Ave, 7th Floor, New York, NY 10022.Abstract |
Background |
The mass media is increasingly important in shaping a range of health beliefs and behaviors.
Objective |
We examined the association among mass media health information exposure (general health, cancer, sun protection information), skin cancer beliefs, and sun protection behaviors.
Methods |
We used a general population national probability sample comprised of 1633 individuals with no skin cancer history (Health Information National Trends Survey, 2005, National Cancer Institute) and examined univariate and multivariate associations among family history of skin cancer, mass media exposure, skin cancer beliefs, and sun protection (use of sunscreen, shade seeking, and use of sun-protective clothing).
Results |
Mass media exposure was higher in younger individuals, and among those who were white and more highly educated. More accurate skin cancer beliefs and more adherent sun protection practices were reported by older individuals, and among those who were white and more highly educated. Recent Internet searches for health or sun protection information were associated with sunscreen use.
Limitations |
Study limitations include the self-report nature of sun protection behaviors and cross-sectional study design.
Conclusion |
We identify demographic differences in mass media health exposure, skin cancer beliefs, and sun protection behaviors that will contribute to planning skin cancer awareness and prevention messaging across diverse population subgroups.
Le texte complet de cet article est disponible en PDF.Key words : health communication, skin cancer beliefs, sun protection behaviors
Plan
| Supported in part by National Cancer Institute grants K07CA98106 (Dr Hay), 5R25CA057708-13 (Dr Coups; Principal Investigator: Paul F. Engstrom, MD) and ACS MRSG-07-165-01 CPPB (Dr Ford). |
|
| Conflicts of interest: None declared. |
Vol 61 - N° 5
P. 783-792 - novembre 2009 Retour au numéro
Article précédent
- Clinical genetic testing for familial melanoma in Italy: A cooperative study
- William Bruno, Paola Ghiorzo, Linda Battistuzzi, Paolo A. Ascierto, Monica Barile, Sara Gargiulo, Francesca Gensini, Sara Gliori, Michele Guida, Maurizio Lombardo, Siranoush Manoukian, Chiara Menin, Sabina Nasti, Paola Origone, Barbara Pasini, Lorenza Pastorino, Bernard Peissel, Maria Antonietta Pizzichetta, Paola Queirolo, Monica Rodolfo, Antonella Romanini, Maria Chiara Scaini, Alessandro Testori, Maria Grazia Tibiletti, Daniela Turchetti, Sancy A. Leachman, Giovanna Bianchi Scarrà, IMI, the Italian Melanoma Intergroup
- Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks
- S. Priya Sivanesan, Shilpa Gattu, Judith Hong, Arianne Chavez-Frazier, Grace D. Bandow, Farah Malick, Greg Kricorian, John Koo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?